Euro-Med Laboratories Phil Balance Sheet Health
Financial Health criteria checks 2/6
Euro-Med Laboratories Phil has a total shareholder equity of ₱6.0B and total debt of ₱4.2B, which brings its debt-to-equity ratio to 69.7%. Its total assets and total liabilities are ₱10.9B and ₱4.9B respectively. Euro-Med Laboratories Phil's EBIT is ₱715.7M making its interest coverage ratio 2.5. It has cash and short-term investments of ₱1.2B.
Key information
69.7%
Debt to equity ratio
₱4.15b
Debt
| Interest coverage ratio | 2.5x |
| Cash | ₱1.20b |
| Equity | ₱5.96b |
| Total liabilities | ₱4.95b |
| Total assets | ₱10.91b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: EURO's short term assets (₱5.3B) exceed its short term liabilities (₱3.9B).
Long Term Liabilities: EURO's short term assets (₱5.3B) exceed its long term liabilities (₱1.0B).
Debt to Equity History and Analysis
Debt Level: EURO's net debt to equity ratio (49.5%) is considered high.
Reducing Debt: EURO's debt to equity ratio has increased from 67.7% to 69.7% over the past 5 years.
Debt Coverage: EURO's debt is not well covered by operating cash flow (3.9%).
Interest Coverage: EURO's interest payments on its debt are not well covered by EBIT (2.5x coverage).